<DOC>
	<DOCNO>NCT00489060</DOCNO>
	<brief_summary>A trial determine cryoablation effective radiation treatment men localize prostate cancer .</brief_summary>
	<brief_title>A Randomized Trial External Beam Radiotherapy Versus Cryoablation Patients With Localized Prostate Cancer</brief_title>
	<detailed_description>Men newly diagnose localized prostate cancer randomly assign cryoablation external beam radiotherapy ( median dose 68 Gy ) . All patient receive neoadjuvant antiandrogen therapy . The primary endpoint disease progression 36 month base trifecta definition failure : ( ) radiological evidence metastatic disease b ) initiation antineoplastic therapy c ) biochemical failure ) . Two definition biochemical failure use : 1 ) rise PSA final value &gt; 1.0 ng/mL 2 ) rise PSA nadir + 2 ng/mL . Secondary endpoint overall survival , disease-specific survival , positive prostate biopsy 36 month .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Clinically localized prostate cancer PSA &lt; 20ng/ml Negative bone scan Previous TURP Previous hormone therapy</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Cryoablation</keyword>
	<keyword>Radiation</keyword>
	<keyword>Prostate Cancer</keyword>
</DOC>